Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reply to H. Seibert et al

Christine N Bailey1, Brian J Martin1, Valentina I Petkov2

  • 1Castle Biosciences, Inc, Friendswood, TX.

JCO Precision Oncology
|September 30, 2024
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determinants of geographic variation in the incidence of adult nonmalignant meningioma in the United States, 2010-2019.

Cancer·2025
Same author

CGE25-104: The 31-GEP Identifies Patients With Early-Stage I-IIA Cutaneous Melanoma at High Risk of Melanoma-Specific and Overall Mortality.

Journal of the National Comprehensive Cancer Network : JNCCN·2025
Same author

Integrating the melanoma 31-gene expression profile test with clinical and pathologic features can provide personalized precision estimates for sentinel lymph node positivity: an independent performance cohort.

World journal of surgical oncology·2024
Same author

Assessing sociodemographic and regional disparities in Oncotype DX Genomic Prostate Score uptake.

Cancer·2024
Same author

NCI SEER-Linked Virtual Tissue Repository Pilot.

Journal of the National Cancer Institute. Monographs·2024
Same author

Reporting tumor genomic test results to SEER registries via linkages.

Journal of the National Cancer Institute. Monographs·2024
Same journal

Identification of a Novel <i>GOLGB1-RET</i> Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib.

JCO precision oncology·2026
Same journal

Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.

JCO precision oncology·2026
Same journal

Perspectives From an Expert-Guided Discussion on Maximizing the Research Potential of Small Biopsy Tissue.

JCO precision oncology·2026
Same journal

Complete Response to Immune Checkpoint Inhibitor-Based Combination Therapy in PD-L1-High, Tumor Mutational Burden-Low Ovarian Sarcomatoid Squamous Cell Carcinoma.

JCO precision oncology·2026
Same journal

Emergence of Microsatellite Instability in an Oncogene-Driven Non-Small Cell Lung Cancer Harboring a Canonical <i>EGFR</i> Mutation: A Molecular Tumor Board Discussion.

JCO precision oncology·2026
Same journal

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
See all related articles